1st Quarter - Report
THE MCMANUS GROUP for IVX HEALTH
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. International Pricing Index model (83 FR 54546). Supervision requirements in CMS-1744-IFC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| WILLIAM RHYNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.